This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Feb;17(2):127-128.

doi: 10.1016/S1473-3099(16)30381-4. Epub 2016 Nov 17.

Time to review treatment of isoniazid-resistant tuberculosis?

Lia D'Ambrosio¹, Giovanni B Migliori¹, Giovanni Sotgiu²

Affiliations

Affiliations

¹ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, IRCCS, Care and Research Institute, Via Roncaccio 16, 21049 Tradate, Italy; Public Health Consulting Group, Lugano, Switzerland.
² Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari-Research, Medical Education, and Professional Development Unit, AOU Sassari, Sassari, Italy.

PMID: 27865889
DOI: 10.1016/S1473-3099(16)30381-4

Comment

Time to review treatment of isoniazid-resistant tuberculosis?

Lia D'Ambrosio et al. Lancet Infect Dis. 2017 Feb.

. 2017 Feb;17(2):127-128.

doi: 10.1016/S1473-3099(16)30381-4. Epub 2016 Nov 17.

Authors

Lia D'Ambrosio¹, Giovanni B Migliori¹, Giovanni Sotgiu²

Affiliations

¹ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, IRCCS, Care and Research Institute, Via Roncaccio 16, 21049 Tradate, Italy; Public Health Consulting Group, Lugano, Switzerland.
² Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari-Research, Medical Education, and Professional Development Unit, AOU Sassari, Sassari, Italy.

PMID: 27865889
DOI: 10.1016/S1473-3099(16)30381-4

No abstract available

PubMed Disclaimer

Comment on

Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis.
Gegia M, Winters N, Benedetti A, van Soolingen D, Menzies D. Gegia M, et al. Lancet Infect Dis. 2017 Feb;17(2):223-234. doi: 10.1016/S1473-3099(16)30407-8. Epub 2016 Nov 17. Lancet Infect Dis. 2017. PMID: 27865891

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations